| Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
|---|
| 04/19/2011 | US7927821 Methods of screening for compounds which bind G protein-coupled receptors |
| 04/19/2011 | US7927622 Methods of transnasal transport/immunization with highly adaptable carriers |
| 04/19/2011 | CA2591257C Heteroarylpiperidines, pyrrolidines and piperazines and their use as antipsychotics and analgetics |
| 04/19/2011 | CA2571133C Fused benzamide compound and vanilloid receptor 1 (vr1) activity inhibitor |
| 04/19/2011 | CA2486495C 9-alpha-substituted estratrienes as selectively active estrogens |
| 04/19/2011 | CA2476012C Substituted pyridinones as modulators of p38 map kinase |
| 04/19/2011 | CA2450946C Use of branched-chain fatty acids and derivatives thereof for the treatment of pain |
| 04/19/2011 | CA2441099C Proanthocyanidins for the treatment of amyloid and alpha-synuclein diseases |
| 04/19/2011 | CA2378778C Il-16 antagonists |
| 04/19/2011 | CA2362496C Polypeptide variants with increased heparin-binding ability |
| 04/16/2011 | CA2777223A1 2h-pyrrol-5-amine derivatives as alpha adrenergic receptor modulators |
| 04/14/2011 | WO2011044587A2 Cytoprotective or therapeutic plant composition |
| 04/14/2011 | WO2011044540A1 Topical formulation comprising etoricoxib and a zwitterionic surfactant |
| 04/14/2011 | WO2011044229A1 2h-pyrrol-5-amine derivatives as alpha adrenergic receptor modulators |
| 04/14/2011 | WO2011044122A1 Compositions and methods of treatment that include plant extracts |
| 04/14/2011 | WO2011043735A1 A composition for modulating immune responses |
| 04/14/2011 | WO2011043455A1 Orally administrable liquid formulation containing acetaminophen |
| 04/14/2011 | WO2011043453A1 Activator for peroxisome proliferator activated receptor |
| 04/14/2011 | WO2011043371A1 Oxazole compound |
| 04/14/2011 | WO2011042399A1 Bicyclic heterocycles and their use as ccr2 receptor antagonists |
| 04/14/2011 | WO2011041870A1 Non-steroidal anti-inflammatory drugs coadministered with nitric oxide amino acid ester compounds as prophylaxis in hypertensive patients |
| 04/14/2011 | WO2011021203A3 Desferrioxamine-metal complexes for the treatment of immune-related disorders |
| 04/14/2011 | WO2011016050A3 Novel compounds as modulators of glucocorticoid receptors |
| 04/14/2011 | WO2010134790A3 Anti-inflammatory composition containing macrolactin a and a derivative thereof as active ingredients |
| 04/14/2011 | US20110086913 Methods for treating myofascial, muscle, and/or back pain |
| 04/14/2011 | US20110086910 Method of treating or preventing pain |
| 04/14/2011 | US20110086907 Acne treatment |
| 04/14/2011 | US20110086906 Methods for treatment or prevention of diseases associated with functional disorder of regulatory t cells |
| 04/14/2011 | US20110086899 Pharmaceutical compositions for oral administration |
| 04/14/2011 | US20110086893 Oxa- and thiadiazoles and their use as metalloproteinase inhibitors |
| 04/14/2011 | US20110086891 Solid Forms of 2-(2,4-Difluorophenyl)-6-(1-(2,6-Difluorophenyl)Ureido)Nicotinamide) |
| 04/14/2011 | US20110086880 Novel alkyl substituted piperidine derivatives and their use as monoamine neurotransmitter re-uptake inhibitors |
| 04/14/2011 | US20110086879 Carboxamide compounds and their use as calpain inhibitors |
| 04/14/2011 | US20110086866 Inhibitors of bruton's tyrosine kinase |
| 04/14/2011 | US20110086864 N-hydroxyamide derivatives and use thereof |
| 04/14/2011 | US20110086857 N-((1r,2s,5r)-5-(tert-butylamino)-2-((s)-3-(7-tert-butylpyrazolo[1,5-a][1,3,5]triazin-4-ylamino)-2-oxopyrrolidin-1-yl)cyclohexyl)acetamide, a dual modulator of chemokine receptor activity, crystalline forms and processes |
| 04/14/2011 | US20110086856 Compositions useful as inhibitors of protein kinases |
| 04/14/2011 | US20110086855 Novel compounds as cannabinoid receptor ligands and uses thereof |
| 04/14/2011 | US20110086849 novel benzoxazine benzimidazole derivative, a pharmaceutical composition comprising the same, and ause thereof |
| 04/14/2011 | US20110086846 Azaindazole Compounds As CCR1 Receptor Antagonists |
| 04/14/2011 | US20110086843 Thiazole Derivatives and Use Thereof |
| 04/14/2011 | US20110086838 Novel compounds as cannabinoid receptor ligands |
| 04/14/2011 | US20110086834 Alkynyl alcohols as kinase inhibitors |
| 04/14/2011 | US20110086832 Novel compounds as cannabinoid receptor ligands |
| 04/14/2011 | US20110086820 Analgesic agent comprising cyclic phosphatidic acid derivative |
| 04/14/2011 | US20110086819 Novel phosphonic acid compounds as inhibitors of serine proteases |
| 04/14/2011 | US20110086815 Novel compositions containing xanthohumol-cyclodextrin complexes |
| 04/14/2011 | US20110086810 HYDROXYL, KETO, AND GLUCURONIDE DERIVATIVES OF 3-(4-(7H-PYRROLO[2,3-d] PYRIMIDIN-4-YL)-1H-PYRAZOL-1-YL)-3-CYCLOPENTYLPROPANENITRILE |
| 04/14/2011 | US20110086808 Modified therapeutic agents |
| 04/14/2011 | US20110086806 Polypeptides that Bind IL-23R |
| 04/14/2011 | US20110086801 Prevention and reduction of blood loss |
| 04/14/2011 | US20110086795 Small peptide modulators of potassium channel trafficking |
| 04/14/2011 | US20110086119 Preparation for the relief of disease |
| 04/14/2011 | US20110086108 Dissolving powders that can be mixed with water and used as an oral rinse |
| 04/14/2011 | US20110086105 Methods for identifying novel nucleic acid regulatory elements and compounds that affect the regulation |
| 04/14/2011 | US20110086074 Combinations of niacin and an oxicam |
| 04/14/2011 | US20110086073 NANOMETER-SIZED PRODRUGS OF NSAIDs |
| 04/14/2011 | US20110086068 Compositions and Methods for Tissue Engineering, Tissue Regeneration and Wound Healing |
| 04/14/2011 | US20110086060 Novel compositions and their use |
| 04/14/2011 | US20110086057 OX40R Binding Agents |
| 04/14/2011 | US20110086050 Glycoprotein compositions |
| 04/14/2011 | US20110086046 Treatment of MS with goat serum |
| 04/14/2011 | US20110086045 Method for enhancing growth or increasing feed efficiency through reducing binding between endotoxin and its receptor in the gastrointestinal tract |
| 04/14/2011 | US20110086037 Method of treating inflammatory disorders |
| 04/14/2011 | US20110086033 Method of inhibiting osteoclast activity |
| 04/14/2011 | US20110086017 Medical Food composition and methods for management of inflammatory processes in mammals |
| 04/14/2011 | US20110086010 Methods, Systems, and Apparati for Cellular Therapeutic Agent Preparation and Delivery |
| 04/14/2011 | US20110085996 External preparation composition for skin comprising ginseng flower or ginseng seed extracts |
| 04/14/2011 | US20110085975 Hypoxia-selective, weakly basic 2-nitroimidazole delivery agents and methods of use thereof |
| 04/14/2011 | US20110083991 Hyaluronic acid derivative and drug containing the same |
| 04/14/2011 | US20110083984 Substituted 2,3-dihydroimidazo[1,2-c]quinazoline Derivatives Useful for Treating Hyper-Proliferative Disorders and Diseases Associated with Angiogenesis |
| 04/14/2011 | DE102009049662A1 2,5-Disubstituierte 2H-Indazole als EP2-Rezeptor-Antagonisten 2,5-disubstituted 2H-indazoles as EP2-receptor antagonists |
| 04/14/2011 | CA2774215A1 Bicyclic heterocycles and their use as ccr2 receptor antagonists |
| 04/14/2011 | CA2773713A1 Novel trpa1 antagonists |
| 04/14/2011 | CA2773576A1 Apogossypolone derivatives as anticancer agents |
| 04/13/2011 | EP2308975A1 Antibody molecules having specificity for human tumor necrosis factor alpha, and use thereof |
| 04/13/2011 | EP2308876A1 Aza-bicycloalkyl ethers and their use as alpha7-nAChR agonists |
| 04/13/2011 | EP2308861A1 Macrocyclic compounds useful as pharmaceuticals |
| 04/13/2011 | EP2308855A1 2,4-Diaminopyrimidine derivatives |
| 04/13/2011 | EP2308848A1 Quinoline-derived amide modulators of vanilloid VR1 receptor |
| 04/13/2011 | EP2308846A2 Caspase inhibitors and uses thereof |
| 04/13/2011 | EP2308845A2 Caspase inhibitors and uses thereof |
| 04/13/2011 | EP2308844A2 Caspase inhibitors and uses thereof |
| 04/13/2011 | EP2308842A1 Pharmaceutical compositions |
| 04/13/2011 | EP2308833A2 Cyclic protein tyrosine kinase inhibitors |
| 04/13/2011 | EP2308828A2 CaSR antagonist |
| 04/13/2011 | EP2308565A2 Oral care compositions containing free-b-ring flavonoids and flavans |
| 04/13/2011 | EP2308498A1 Administration of Bifidobacterium breve during infancy to prevent inflammation later in life |
| 04/13/2011 | EP2307418A1 Novel phenylimidazopyrazines |
| 04/13/2011 | EP2307414A2 Pi3k isoform selective inhibitors |
| 04/13/2011 | EP2307413A1 Novel phenyl-imidazopyridines and pyridazines |
| 04/13/2011 | EP2307411A1 Triazolopyridine compounds useful as kinase inhibitors |
| 04/13/2011 | EP2307397A1 6-substituted phenoxychroman carboxylic acid derivatives |
| 04/13/2011 | EP2307376A1 Novel phenylamino isonicotinamide compounds |
| 04/13/2011 | EP2307375A1 Phenanthrenone compounds, compositions and methods |
| 04/13/2011 | EP2307364A1 Isoindolone derivatives as mek kinase inhibitors and methods of use |
| 04/13/2011 | EP2307022A1 Enhanced nsaid formulations |
| 04/13/2011 | EP2307012A1 Nitrogen heterocycle derivatives as proteasome modulators |
| 04/13/2011 | EP2307004A1 Novel treatments |
| 04/13/2011 | EP1558640B1 Trimeric binding proteins for trimeric cytokines |